A Denver-based company hopes to be the state’s first to study the effects of marijuana on Alzheimer’s disease, thanks to a newly available research and development license in the city. MedPharm Holdings plans to apply for a Denver marijuana R&D license to test delta-9 tetrahydrocannabinol (THC), cannabidiol (CBD) and other cannabinoids’ effects on Alzheimer’s and […]
Lab Testing
Call for National Lab Testing Standards
Medical and Recreational Marijuana: Legal Issues, Operational Challenges and Regulatory Hurdles That Marijuana-Related Businesses Frequently Encounter PART 3 of 6: An Overview of How the Lack of National Standards for Laboratory Tests of Marijuana Products Affects the Public Health and the Marijuana Industry This article is the third part of a six-part series discussing the […]
In Random Mold Tests at 25 Denver Dispensaries, 80 Percent Fail
Denver recently conducted random tests of more than two dozen local dispensaries to learn more about potential yeast and mold issues with marijuana, and the results weren’t good. On August 19, the City of Denver sent a notice to every licensed marijuana dispensary in the city, warning that investigators would be conducting random assessments at about […]
Marijuana testing labs: Will Maine have enough?
Maine is finalizing its testing rules for recreational marijuana, spelling out what a lab must do to get a state license and what safety and potency checks must be done on any marijuana products before they can be sold when the market opens in March. The proposed rules cover everything from how samples are collected (by the […]
Marijuana testing facility fined $100K in settlement with Michigan state regulators
A marijuana safety compliance facility was fined $100,000 as part of a settlement agreement with state regulators. Iron Laboratories, LLC, a Walled Lake marijuana testing facility, was ordered to cease operations in August after Michigan’s Marijuana Regulatory Agency found the evidence of various violations of state law. In addition to the fine, the business is […]
First of Its Kind Partnership in the Cannabis Industry to Bridge State Rulemaking and the Creation of Cannabis Standards
Partnership between ATACH and A2LA will Pave the Way for New Quality Standards, Increase Consistency Between Labs, Bring Uniformity in State Testing Regulations, and Ensure Safe Consumer Products Washington, D.C. – A2LA and the American Trade Association for Cannabis and Hemp (ATACH) today announced the first ever partnership agreement between a laboratory accreditation body and […]
California Marijuana Products Are Failing Tests At An Alarming Rate
Nearly 20 percent of marijuana products in California have failed tests for potency and purity since the state started requiring the checks on July 1, a failure rate some in the industry say has more to do with unrealistic standards and technical glitches than protecting consumer safety. The testing has been especially tough on cannabis-infused cookies, candies […]
Medical Marijuana’s ‘Catch-22’: Limits On Research Hinder Patient Relief
By the time Ann Marie Owen, 61, turned to marijuana to treat her pain, she was struggling to walk and talk. She was also hallucinating. For four years, her doctor prescribed a wide range of opioids for transverse myelitis, a debilitating disease that caused pain, muscle weakness and paralysis. The drugs not only failed to […]
Arizona Legislatures Want To Test Medical Marijuana Quality And Reduce Prices
PHOENIX — A Lake Havasu City senator figures it’s the state’s obligation to ensure medical-marijuana buyers are getting a safe product that’s as strong as advertised. His proposal to have the state inspect growing facilities — and to reduce fees for medical-marijuana users — already has the support of more than three-fourths of the Legislature. […]
D.C. Policy Summit – Researchers Working on First-Ever Federally-Approved Medical Marijuana Study Fighting to Overcome Significant DEA, NIDA Obstacles
The 10th Annual DuPont Summit on Science, Technology and Environment Policy held in Washington, D.C. on December 1 is usually reserved for issues like equitable access to broadband technology or building sustainability in policy or cybersecurity risk management. This year, the summit also included a session on cannabis, “Medical Marijuana-Miracle or Madness?” – a title […]
